[1]
“Gemcitabine and vinorelbine: treatment option in recurrent platinum – resistant ovarian cancer”, Eur J Oncol, vol. 22, no. 3-4, pp. 131–137, Mar. 2018, Accessed: Jul. 18, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/6086